Mark Strobeck - 20 May 2025 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Reporting relationship: President and CEO, Director
Issuer ticker: RMTI
Reported as of: 20 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 May 2025, 18:56:20 UTC
Prior SEC filing: 02 Apr 2025
Next SEC filing: 03 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck

Key filing fact

Mark Strobeck filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 21 May 2025.

Key facts

This page summarizes Mark Strobeck's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 May 2025, 18:56.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001599219 Primary reporting owner

Strobeck Mark

Relationship: President and CEO, Director
Address: C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD, WIXOM
Signature: /s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck
Signature date: 21 May 2025

This filing has been restated. Open the amended filing.

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMTI transaction

Common Stock

Award

Transaction value: $0
Shares: +220,000
Change %: +176%
Price: $0.000000
Shares after: 344,678
Date: 20 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RMTI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +308,000
Change %
Price: $0.000000
Shares after: 308,000
Date: 20 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 308,000
Exercise price: $1.07
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units vest on May 20, 2027, subject to the Reporting Person's continued service to the Issuer.

Footnote F2

Stock options vest 1/3 on the first anniversary of May 20, 2025, with the remaining vesting in equal monthly installments through May 20, 2028, subject to the Reporting Person's continued service to the Issuer.